Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (61-70 of 293) with videos related to

Pageof 30
Sort By:
Vaccine|October 12, 2020
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccinePhilip C LaTourette, Sita Awasthi, Angela Desmond, et al.
Vaccine|January 29, 2026
Neonatal mice immune response to COVID-19 mRNA vaccineLeda Lotspeich-Cole, Mukesh Kumar Jha, Swetha Parvathaneni, et al.
Science Translational Medicine|January 10, 2020
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in miceElinor Willis, Norbert Pardi, Kaela Parkhouse, et al.
Nature Communications|December 14, 2021
An ionizable lipid toolbox for RNA deliveryXuexiang Han, Hanwen Zhang, Kamila Butowska, et al.
Retrovirology|July 15, 2011
SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaquesHaitao Hu, Lucio Gama, Pyone P Aye, et al.
Nucleic Acids Research|May 12, 2010
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activationBart R Anderson, Hiromi Muramatsu, Subba R Nallagatla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Elevated Pre-Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infectionShruthi Ravimohan, Neo Tamuhla, Kebatshabile Nfanyana, et al.
Frontiers in Immunology|October 31, 2022
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma modelChutamath Sittplangkoon, Mohamad-Gabriel Alameh, Drew Weissman, et al.
Bio-Protocol|November 1, 2021
Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNAElissa Everton, Fatima Rizvi, Anna R Smith, et al.
Ebiomedicine|March 26, 2016
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral TherapyShruthi Ravimohan, Neo Tamuhla, Shiang-Ju Kung, et al.
Pageof 30

Showing results (61-70 of 293) with videos related to

Sort By:
Pageof 30
Vaccine|October 12, 2020
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccinePhilip C LaTourette, Sita Awasthi, Angela Desmond, et al.
Vaccine|January 29, 2026
Neonatal mice immune response to COVID-19 mRNA vaccineLeda Lotspeich-Cole, Mukesh Kumar Jha, Swetha Parvathaneni, et al.
Science Translational Medicine|January 10, 2020
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in miceElinor Willis, Norbert Pardi, Kaela Parkhouse, et al.
Nature Communications|December 14, 2021
An ionizable lipid toolbox for RNA deliveryXuexiang Han, Hanwen Zhang, Kamila Butowska, et al.
Retrovirology|July 15, 2011
SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaquesHaitao Hu, Lucio Gama, Pyone P Aye, et al.
Nucleic Acids Research|May 12, 2010
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activationBart R Anderson, Hiromi Muramatsu, Subba R Nallagatla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Elevated Pre-Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infectionShruthi Ravimohan, Neo Tamuhla, Kebatshabile Nfanyana, et al.
Frontiers in Immunology|October 31, 2022
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma modelChutamath Sittplangkoon, Mohamad-Gabriel Alameh, Drew Weissman, et al.
Bio-Protocol|November 1, 2021
Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNAElissa Everton, Fatima Rizvi, Anna R Smith, et al.
Ebiomedicine|March 26, 2016
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral TherapyShruthi Ravimohan, Neo Tamuhla, Shiang-Ju Kung, et al.
Pageof 30